Xcelerate, Inc. Applies to Trade on the OTCQB Venture Marketplace
MAULDIN, SC / ACCESSWIRE / June 22, 2022 / Xcelerate, Inc. (OTC PINK:XCRT) today announced that it has initiated its...
Day: June 22, 2022
Moderna Announces Bivalent Booster mRNA-1273.214 Demonstrates Potent Neutralizing Antibody Response Against Omicron Subvariants BA.4 And BA.5
mRNA-1273.214 Exhibited a Greater Than 5-Fold Boost in Neutralizing Antibodies Against BA.4 and BA.5 Subvariants in Phase 2/3 StudyData Being...
Aclarion to Present 2-year Follow Up Data on Pivotal Clinical Trial Linking Nociscan to Better Surgical Outcomes for Discogenic Low Back Pain
Superior Clinical Outcomes for NociscanTM Proving to be Durable at Two YearsTwo Year Results and the Schedule of Future Clinical...
NuGen M.D. Launches PetJet(TM) Providing Needle-Free Injections for Domesticated Pets
Reducing Fear and Risk of Injury for Pet Owners and their Furry Loved OnesTORONTO, ON / ACCESSWIRE / June 22,...
Brinter Launches Upgraded Pneuma Triaxial Pro “Digital Pneuma Pro“ Bioprinting Head Capable Of Doing Microfluidic Manipulations To Enable More Personalized Tissue Cell Therapy And Transform How Diseases Are Treated
Currently being piloted with selected customers, the new 3D bioprinting head provides a revolutionary approach to regenerative medicine and replacing...
Icario’s Annual Healthcare Innovation Summit Trailblaze 2022 Taking Place Aug. 10-11 in Minneapolis
Speakers Include Blue Zones Founder and Bestselling Author Dan Buettner and Healthcare Leaders From Aetna/CVS Health, Anthem, Medicaid Health Plans...
TELUS Health releases annual Health Drug Data Trends Report 2022: Pandemic side effects include rise in medications for depression and ADHD
TELUS Health forecasts that by the end of 2026, specialty drugs can account for almost half of the average eligible...
Equip Publishes Study Showing Virtual Treatment is Highly Effective for Eating Disorders as Company Expands to 50 States
Published in Eating Disorders: The Journal of Treatment & Prevention, Study Finds FBT via Telemedicine Leads to Positive Patient Outcomes...
Bitech Technologies Signs Letter of Intent with Value Added Reseller Paladin Power
Costa Mesa, CA, June 22, 2022 (GLOBE NEWSWIRE) -- Bitech Technologies Corporation (formerly, Spine Injury Solutions, Inc) (the “Company”), a...
Nanomix Initiates New Clinical Study for the eLab S1 Panel
Study incorporates the use of the Nanomix eLab® S1 Panel within the Emergency Department of Hospital Clinico San Carlos in...
ViaDerma Announces the Implementation of Internal Quality Control Measures for its New Vitastem Products
The Company’s improved, new Vitastem products have recently begun large scale productionLOS ANGELES, June 22, 2022 (GLOBE NEWSWIRE) -- ViaDerma,...
Biora Therapeutics Announces Presentation at the 2022 Parenteral Drug Association Universe of Pre-Filled Syringes and Injection Devices Conference
SAN DIEGO, June 22, 2022 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutics,...
Berkeley Lights to Participate at the 27th European Society for Animal Cell Technology Meeting
Lonza and Edinburgh Genome Foundry to present their high-throughput single-cell screening workflow use cases using the Beacon® PlatformEMERYVILLE, Calif., June...
Healthy Extracts’ WHITNEY JOHNS ACTIVE™ Clinically Proven to Enhance Physical Performance by Increasing Nitric Oxide by 73% and Oxygen Consumption by 24%
Image 1 Whitney Johns ACTIVELAS VEGAS, June 22, 2022 (GLOBE NEWSWIRE) -- Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator...
CytoDyn to Hold Webcast to Provide a Quarterly Company Update
VANCOUVER, Washington, June 22, 2022 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a late-stage biotechnology company...
Cyclerion Therapeutics to Discuss CY6463 MELAS Clinical Data at a Webinar Hosted by United Mitochondrial Disease Foundation
Company to discuss positive topline and additional clinical data for CY6463 in MELAS patients Mitochondrial disease clinician-researcher, Amel Karaa, M.D.,...
Biomea Fusion Announces First Patient Dosed in Multiple Myeloma Cohort of COVALENT-101 Trial
BMF-219, a covalent menin inhibitor, is the first menin inhibitor administered to patients with relapsed/refractory (R/R) multiple myeloma (MM)Patients with...
Athenex Announces Sale of Revenues from U.S. and European Royalty and Milestone Interests in Klisyri® (tirbanibulin) to Sagard Healthcare Partners and Oaktree
Company executes on strategy to extend cash runway by monetizing non-core assetsTotal transaction value of $85 million; at least $80...
Simply Better Brands Corp. Expands its Strategic Partnership With New Frontier Presents to Include Metaverse Shopping
PureKana Wellness, a Simply Better Brands asset, has expanded its current metaverse footprint by launching its Metaverse Shop Image 1...
Rhythm Pharmaceuticals Launches IMCIVREE® (setmelanotide) in Germany for the Treatment of Obesity and Control of Hunger Associated with POMC or LEPR Deficiency
BOSTON, June 22, 2022 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company committed to transforming the...